Medical imaging and radiology
Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryHeartflow medical AI product profile
Non-invasive AI heart-care platform for coronary CTA-derived anatomy, physiology, and plaque information.
Medical imaging and radiology
Best fit
Cardiology and imaging programs using CCTA to evaluate coronary artery disease and support treatment planning.
- Primary use case
- AI-powered coronary CTA analysis, FFRCT physiology analysis, plaque analysis, and coronary roadmap workflows
- Audience
- Cardiology teams, coronary CTA programs, imaging centers, and cardiovascular service lines
- Risk level
- High
- Pricing signal
- Provider and enterprise pricing varies by product, geography, and reimbursement workflow; verify current terms.
- Official sources
- 6 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Heartflow as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Separate FFRCT, plaque, roadmap, and other Heartflow modules because each may have different clearance, indication, contraindication, and reimbursement requirements. |
|---|---|
| Privacy | Review CCTA image submission, cloud analysis, report delivery, retention, access controls, and cardiology-record integration before production use. |
| Evidence | Assess clinical utility for the target coronary-artery-disease population, scanner protocols, image quality thresholds, downstream testing, and treatment changes. |
| Workflow | Best governed as cardiology-reviewed coronary CTA analysis feeding shared decision-making, referral, preventive-care, or cath-lab planning workflows. |
Where Heartflow fits
Heartflow describes AI-powered non-invasive heart-care analysis for coronary CTA, including FFRCT, plaque, and roadmap analysis; company materials include FDA clearance history and a 2025 next-generation plaque-analysis clearance announcement.
Not for: Emergency cardiac diagnosis, unsupported scans, or treatment decisions without cardiologist interpretation and product-specific intended-use review.
What to verify before using Heartflow
- Which Heartflow product is being used: FFRCT, Plaque Analysis, Roadmap Analysis, or another module.
- FDA clearance, indication, required CCTA image quality, contraindications, and geography-specific availability.
- How results are reviewed by cardiology, documented, billed, and incorporated into shared decision-making.
- Evidence for the target patient population, scanner protocols, clinical utility, and downstream testing impact.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.heartflow.com / about
- www.heartflow.com / indications
- www.heartflow.com / press-release / Heartflow-plaque-analysis-and-roadmap-analysis-fda-510k-clearance
- ir.heartflow.com / node / 6481
- www.heartflow.com / wp-content / uploads
- www.heartflow.com / press-release / nextgen-plaque-analysis
Related medical AI products
Medical imaging and radiology
Viz.ai
AI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Medical imaging and radiology
Ferrum Health
Clinical AI governance and deployment platform for health systems adopting multiple imaging or clinical AI models.
Medical imaging and radiology
Blackford Platform
Enterprise medical imaging AI platform for evaluating, deploying, routing, and monitoring multiple radiology AI applications.